Nussbaum Ran 4
4 · LB PHARMACEUTICALS INC · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Nussbaum Ran
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-09-10+22,449→ 22,449 totalExercise: $15.00Exp: 2035-09-09→ Common Stock (22,449 underlying)
Footnotes (1)
- [F1]The option award shall vest in three (3) equal annual installments on September 10, 2026, September 10, 2027 and September 10, 2028, subject to the Reporting Person's continuous service through such vesting date.